BIIB

Biogen Idec Inc. News Headlines

$336.39
*  
0.94
0.28%
Get BIIB Alerts
*Delayed - data as of Jul. 28, 2014  -  Find a broker to begin trading BIIB now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
View:    BIIB After Hours
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save stocks for next time
Viewing
Filtered By
Ordered By

bluebird bio, Inc. (BLUE) in Focus: Stock Surges 10.24% - Tale of the Tape
7/21/2014 8:44:00 AM - Zacks.com

InsiderInsights.com Daily Round Up: 7/18/14
7/21/2014 6:44:00 AM - Seeking Alpha

Repros Gets Additional FDA Guidance for Androxal - Analyst Blog
7/17/2014 5:20:00 PM - Zacks.com

Lannett Shares Down on Subpoena Receipt from Connecticut AG - Analyst Blog
7/17/2014 5:10:00 PM - Zacks.com

CVS Caremark Forms Clinical Alliances to Boost Health Care - Analyst Blog
7/17/2014 3:20:00 PM - Zacks.com

Arena Pharmaceuticals' Pain Candidate Gets New U.S. Patent - Analyst Blog
7/16/2014 4:30:00 PM - Zacks.com

Hospira Upgraded to Strong Buy on Orchid Facility Buy - Analyst Blog
7/15/2014 5:00:00 PM - Zacks.com

CVS Caremark to Expand with Navarro Discount Pharmacy Buyout - Analyst Blog
7/15/2014 3:10:00 PM - Zacks.com

Will Abbott Laboratories (ABT) Miss This Earnings Season? - Analyst Blog
7/15/2014 12:40:00 PM - Zacks.com

Peregrine Pharmaceuticals' Q4 Loss Narrower than Expected - Analyst Blog
7/15/2014 11:00:00 AM - Zacks.com

Exelixis (EXEL) Soars: Stock Adds 23% in Session - Tale of the Tape
7/15/2014 9:04:00 AM - Zacks.com

Sunesis' Pediatric Plan Accepted in the EU - Analyst Blog
7/14/2014 6:45:00 PM - Zacks.com

Will Johnson & Johnson (JNJ) Beat this Earnings Season? - Analyst Blog
7/14/2014 4:45:00 PM - Zacks.com

Bruker's Inspire Mapping System Fails to Inspire Share Prices - Analyst Blog
7/14/2014 3:20:00 PM - Zacks.com

Hefty Price Tag of Gilead's Sovaldi Questioned Again - Analyst Blog
7/14/2014 11:30:00 AM - Zacks.com

Bristol-Myers to Seek U.S. Approval for Immuno-Oncology Drug - Analyst Blog
7/11/2014 5:30:00 PM - Zacks.com

Oncolytics Up on Patient Enrolment Completion - Analyst Blog
7/11/2014 3:00:00 PM - Zacks.com

Sarepta Therapeutics Slumps: SRPT Tanks 12.9% in Session - Tale of the Tape
7/11/2014 8:42:00 AM - Zacks.com

Should You Get Rid of Kamada (KMDA) Now? - Tale of the Tape
7/11/2014 8:34:00 AM - Zacks.com

Regado's REGULATE-PCI Study Under Clinical Hold - Analyst Blog
7/10/2014 6:30:00 PM - Zacks.com

Myriad Genetics Poised on Strong Fundamentals - Analyst Blog
7/10/2014 6:10:00 PM - Zacks.com

Celgene's Otezla Disappoints in Ankylosing Spondylitis Study - Analyst Blog
7/10/2014 11:30:00 AM - Zacks.com

Lexicon (LXRX) Jumps: Stock Moves 7.6% Higher - Tale of the Tape
7/10/2014 9:46:00 AM - Zacks.com

Cramer's Mad Money - The 4 Horsemen Of Biotech Ride On (7/9/14)
7/10/2014 6:27:00 AM - Seeking Alpha

China Biologic Products, Inc. (CBPO) Jumps: Stock Surges 10.8% - Tale of the Tape
7/9/2014 9:11:00 AM - Zacks.com